HSPA1A and neoplasm: In order to further enhance the medicinal properties of PES, Balaburski et al. developed a derivative of PES, 2-(3-chlorophenyl) ethynesulfonamide (PES-Cl), which showed comparable ability to bind to HSP70 but higher anti-tumor activity compared to PES.